Dialysis disequilibrium syndrome in neurointensive care unit: the benefit of intracranial pressure monitoring

Dialysis disequilibrium syndrome in neurointensive care unit: the benefit of intracranial pressure monitoring

disease characterized by neurological symptoms due to cerebral edema after hemodialysis (HD). However, a direct measurement of intracranial pressure (ICP) rarely objectifi ed this edema [1]. We report the case of a patient whose DDS was diagnosed by an increase of ICP. A 51-year-old man was admitted for severe traumatic brain injury. At admission, an extradural hematoma was evacuated. After sur...

Dialysis Disequilibrium Syndrome: The Changes of Intracranial Pressure

Dialysis Disequilibrium Syndrome (DDS) is a rare but well-known serious complication of dialysis [1]. A clinical deteriorated neurological symptom due to cerebral edema after hemodialysis is defined as the dialysis disequilibrium syndrome, which is similar to symptom that occurs with increased Intracranial Pressure (ICP) [2]. However, the direct evidence of increased ICP is rarely described in ...

Dexmedetomidine in the neurointensive care unit.

Dexmedetomidine is a new alpha-2 agonist with high specificity to alpha-2 receptors. The aim of this review is to present the most recent topics regarding the advantages in using dexmedetomidine in clinical anesthesia and intensive care, while discussing the controversial issue of its harmful effect on cerebral blood flow.

Multimodal monitoring in neurointensive care.

Dialysis Disequilibrium Syndrome

A aggressive dialysis in a grossly azotemic patient, especially one with severe metabolic acidosis, can lead to dialysis disequilibrium syndrome (DDS). Mild forms present as nausea, vomiting, restlessness, and headache. Severe manifestations include seizures, obtundation, coma, and even death. This clinical picture is caused by cerebral edema induced by one or more of the following mechanisms: